A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
At Avantor, everything we do is tied to our unique mission of setting science in motion to create a better world. We are a leading global provider of mission-critical products and services to customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials end markets. Our business model is grounded in supporting our customers from discovery to delivery and Avantor is embedded in virtually every stage of the most important research, scale-up and manufacturing activities in the industries we serve. We work with customers across these sophisticated, science-driven industries that require innovation and adherence to the most demanding technical and regulatory requirements.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.6B | 6.6B | 6.8B | 7.0B | 7.5B | 7.4B |
| Net Income | -530M | -530M | 712M | 321M | 662M | 508M |
| EPS | $-0.78 | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| Free Cash Flow | 495M | 495M | 692M | 724M | 710M | 843M |
| ROIC | -2.1% | -5.7% | 8.7% | 5.0% | 8.2% | 8.1% |
| Gross Margin | 32.7% | 32.7% | 33.6% | 33.9% | 34.6% | 33.9% |
| Debt/Equity | 0.74 | 0.74 | 0.73 | 1.12 | 1.39 | 1.70 |
| Dividends/Share | $0.00 | - | $0.00 | $0.00 | $0.05 | $0.11 |
| Operating Income | -246M | -246M | 1.1B | 696M | 1.1B | 972M |
| Operating Margin | -3.8% | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% |
| ROE | -9.5% | -9.2% | 12.7% | 6.4% | 14.6% | 14.8% |
| Shares Outstanding | 680M | 680M | 684M | 683M | 656M | 598M |
Avantor, Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 11.3x vs a median of 21.2x. The company's 5-year average ROIC is 4.9% with a gross margin of 33.7%. Total shareholder yield (buybacks) is 1.3%. At current prices, the estimated annualized return to fair value is -0.2%.
Avantor, Inc. (AVTR) has a 5-year average return on invested capital (ROIC) of 4.9%. This is below average and may indicate limited pricing power.
Avantor, Inc. (AVTR) has a market capitalization of $5.6B. It is classified as a mid-cap stock.
Avantor, Inc. (AVTR) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.35%.
Avantor, Inc. (AVTR) operates in the Laboratory Analytical Instruments industry, within the Technology sector.
Avantor, Inc. (AVTR) reported annual revenue of $6.6 billion in its most recent fiscal year, based on SEC EDGAR filings.
Avantor, Inc. (AVTR) has a net profit margin of -8.1%. The company is currently unprofitable.
Avantor, Inc. (AVTR) generated $495 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Avantor, Inc. (AVTR) has a debt-to-equity ratio of 0.74. This indicates moderate leverage.
Avantor, Inc. (AVTR) reported earnings per share (EPS) of $-0.78 in its most recent fiscal year.
Avantor, Inc. (AVTR) has a return on equity (ROE) of -9.2%. A negative ROE may indicate losses or negative equity.
Avantor, Inc. (AVTR) has a 5-year average gross margin of 33.7%. This indicates decent pricing power.
The Ledger Terminal provides 9 years of financial data for Avantor, Inc. (AVTR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Avantor, Inc. (AVTR) has a book value per share of $8.19, based on its most recent annual SEC filing.